CREATING TOMORROW S SOLUTIONS ANNUAL PRESS CONFERENCE FOR 216 Dr. Rudolf Staudigl, President & CEO,
Economic Output Increased in Every Region in 216 Worldwide GDP Trend by Region Actual Year-over-Year Change in % Worldwide 3.1 Europe 1.5 Asia 5.7 China 6.7 India 7.6 Japan.9 USA 1.6,. 1, 1. 2. 2, 3, 3. 4. 4, 5, 5. 6, 6. 7, 7. 8, 8.. Sources worldwide: IMF; Asia: ADB; China: National Bureau of Statistics; India: NCAER; Japan: IMF; USA: IMF; Europe: OECD 1
Group Sales Grow to 5.4 Billion in 216 million 6. 5,296 5,44 +2%, 4., 2. 2
At 1.1 Billion, EBITDA 5 Percent Above Prior Year, with EBIT and Net Income for the Year Decreasing Due to Higher Depreciation million EBITDA EBIT Net income 1.25,, 1. 1,49 +5% 1,11 75 5 25 473-23% 366 242-22% 189 Special income from damages received and advance payments retained 3
Chemical Divisions Generate Sales Growth and Boost EBITDA Substantially Sales million million EBITDA 4., 8, 3., 2. 3,326 +2% 3,42 197 26 +24% 6 53 1,186 1,195 32 4 222 659 37 261, 1. 1,943 2,1 2 276 361 WACKER BIOSOLUTIONS WACKER POLYMERS WACKER SILICONES Sales figures are total sales, including internal sales 4
WACKER POLYSILICON Posts Sales Gain, with EBITDA Clearly Down Versus Prior Year Due to Lower Special Income and to Start-Up Costs Sales million million EBITDA 1.2, 1,64 +3% 1,96 6 9 45 42-29% 6 3 286 3 15 Special income from damages received and advance payments retained Sales figures are total sales, including internal sales 5
Siltronic Generates Sales at Prior-Year Level and Lifts EBITDA Strongly Sales million million EBITDA 1., 931 ±% 933 2 75 15 146 124 +18% 5 1 25 5 Sales figures are total sales, including internal sales 6
Investments Drop by Half, with Net Cash Flow Rising Many Times Over million Capital expenditures million Net cash flow million Net financial debt 1., 8 6 834 5 4-49% >1% 3 41 1.2, 8 1,74-8% 993 4 428 2 4 2 1 23 7
Start-Up of Charleston Polysilicon Site Successfully Completed Charleston Site (Tennessee, USA) Production Building 8
WACKER Expands Capacities for Downstream Products in Growth Segments Production Plant for Specialty Silicones at Jincheon (South Korea) Premix Tank for New Dispersions Reactor at Burghausen (Germany) 9
WACKER Continues to Expand Sales Outside of Europe Sales in million, 2.5 ±% 2,253 +4% 2,341, 2. 1,888 1,894, 1.5 +1% 1., 945 951 5 +4% 21 219 Europe The Americas Asia Other 1
Number of Employees Up by 23 in 216 Number of Employees, as of December 31 for Each Year 18., 16,972 17,25, 12. 4,721 5,67 Employees, international Employees, Germany, 6. 12,251 12,138 11
Group Net Assets and Financial Position Are Sound Total Assets, as of Dec. 31, 216: 7.46 Billion Highlights Liquidity of 47 million Fixed assets 64.% Equity 34.8% Unused lines of credit of around 8 million Provisions 34.3% Advance payments from customers of 27 million Inventories 11.3% Receivables 18.5% Cash / securities 6.2% Assets Financial liabilities 19.5% Liabilities / adv. payments received 11.4 % Equity & Liabilities Equity ratio at 35 percent 12
Economic Experts Anticipate Somewhat Stronger Global Growth for 217 Worldwide GDP Trend by Region Actual Year-over-Year Change in % Worldwide 3.4 Europe 1.6 Asia 5.7 China 6.3 India 7.8 Japan 1. USA 2.3,. 1. 1, 2, 2. 3. 3, 4, 4. 5, 5. 6, 6. 7. 7, 8. 8, 9, 9. Sources worldwide: IMF; Asia: ADB; China: ADB; India: ADB; Japan: OECD; USA: OECD; Europe: OECD 13
WACKER SILICONES Expects Higher Sales and Slight EBITDA Increase in 217 Production of Pyrogenic Silica at Burghausen (Germany) Strategic Focus Adding value: increasing the share of high-margin specialty products Innovation: tapping new markets and applications Costs: continuous improvements with capacity utilization held at high level 14
WACKER POLYMERS Sales Up in 217, with EBITDA Expected to Decline Markedly Amid Higher Raw-Material Prices Pilot Reactor for Polymer Dispersions at Nanjing (China) Strategic Focus Expansion: increasing market penetration Substitution: replacing conventional products in existing applications Innovation: developing new products and harnessing additional application fields 15
WACKER BIOSOLUTIONS Expects Sales to Grow Slightly in 217, with EBITDA Below Prior Year Due to Integration Costs for New Site in Spain Cleanroom Facility for Biologics at Jena (Germany) Strategic Focus Market share: spurring growth at biotechnology business Innovation: advancing the commercialization of newly developed products Costs: enhancing productivity and efficiency along supply chains 16
Photovoltaic Market to Grow Further in 217 Installation of New PV Capacity in Megawatts 217 216 Germany 1,5-1,7 1,5 Rest of Europe 5,4-6,2 5,2 USA 12, - 14, 14,6 Japan 7,5 8, 8,3 China 24, - 27, 3, India 8,5-9,5 4,2 Other regions 16,1-18,6 12,2 Total 75, - 85, 76, Sources: PV market in 217: IHS, RTS Corporation, WACKER s own market research; PV market in 216: Germany s Federal Network Agency, Commissariat Général au Développement Durable, IHS, SEIA, RTS Corporation, WACKER s own market research 17
With New Production Site in the USA, WACKER s Total Capacity Is to Increase to 8, Metric Tons This Year Amount of Polysilicon Sold and Nominal Capacity in Metric Kilotons Nominal year-end capacity Amount sold 49 51 56 66 8 3 32 38 6 8 11 18 26 27 28 29 21 211 212 213 214 217e Commissioning of Plants at Charleston Completed in Q3 216 as Planned 18
Semiconductor Business Likely to Post Strong Sales Growth in 217, while EBITDA Should Climb Even Faster Production of a Silicon Monocrystal Wafer Analysis 19
Group Sales Expected to Continue Growing in 217, with Net Income for the Year Forecast at Last Year s Level Outlook for 217 Reported for 216 Outlook for 217 Sales ( million) 5,44 Mid-single-digit percentage increase EBITDA ( million) 1,11 At last year s level, on a comparable basis EBITDA margin (%) 2.4 Slightly below last year s level Net cash flow ( million) 41 At last year s level Capital expenditures ( million) 428 Around 45 Depreciation ( million) 735 Around 72 Net financial debt ( million) 993 Substantially lower than last year Net income for the year ( million) 189 At last year s level 2
WACKER s Focus for Next Few Years Is On Above-Average Growth, Attractive Margins and High Cash Inflow from Operating Activities Investments vs. Depreciation in Million Strategic Pillars until 22 92 834 Investing below deprecation level Growing faster than the chemical-sector average 54 572 428 Focusing on sustainability in every business process Maintaining attractive margins in the business cycle Generating high cash inflows Ø 28-212 Create 213 214 Leverage 215 216 217e 22e CAPEX Depreciation 21
CREATING TOMORROW S SOLUTIONS ANNUAL PRESS CONFERENCE FOR 216 Dr. Rudolf Staudigl, President & CEO, 22